Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Schuchmann

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
European Journal of Gastroenterology & Hepatology|November 17, 2018
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidenceMark Hudson, Marcus Schuchmann
Journal of Hepatology|June 5, 2002
Dead or alive -- NF-kappaB, the guardian which tips the balanceMarcus Schuchmann, Peter R Galle
Hepatology (Baltimore, Md.)|November 26, 2009
Shortcut to deathJörn M Schattenberg, Marcus Schuchmann
Apoptosis : an International Journal on Programmed Cell Death|June 23, 2009
Diabetes and apoptosis: liverJörn M Schattenberg, Marcus Schuchmann
Journal of Hepatology|January 24, 2004
Sensitizing to apoptosis--sharpening the medical swordMarcus Schuchmann, Peter R Galle
European Journal of Gastroenterology & Hepatology|August 17, 2021
Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-αPierre Deltenre, Christian Labenz, Marcus Schuchmann
Current Infectious Disease Reports|February 11, 2011
Posttransplant lymphoproliferative disease in liver transplant patientsChristina Hartmann, Marcus Schuchmann, Tim Zimmermann
Medizinische Klinik (Munich, Germany : 1983)|December 20, 2002
[Apoptosis in disease]Marcus Schuchmann, Peter R Galle, Stephan Kanzler
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2006
Apoptosis in liver diseaseJörn M Schattenberg, Peter R Galle, Marcus Schuchmann
Journal of Gastroenterology and Hepatology|January 5, 2011
Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathwaysJorn Markus Schattenberg, Marcus Schuchmann, Peter Robert Galle
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
European Journal of Gastroenterology & Hepatology|November 17, 2018
Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidenceMark Hudson, Marcus Schuchmann
Journal of Hepatology|June 5, 2002
Dead or alive -- NF-kappaB, the guardian which tips the balanceMarcus Schuchmann, Peter R Galle
Hepatology (Baltimore, Md.)|November 26, 2009
Shortcut to deathJörn M Schattenberg, Marcus Schuchmann
Apoptosis : an International Journal on Programmed Cell Death|June 23, 2009
Diabetes and apoptosis: liverJörn M Schattenberg, Marcus Schuchmann
Journal of Hepatology|January 24, 2004
Sensitizing to apoptosis--sharpening the medical swordMarcus Schuchmann, Peter R Galle
European Journal of Gastroenterology & Hepatology|August 17, 2021
Quality of life as a therapeutic objective in the management of hepatic encephalopathy and the potential role of rifaximin-αPierre Deltenre, Christian Labenz, Marcus Schuchmann
Current Infectious Disease Reports|February 11, 2011
Posttransplant lymphoproliferative disease in liver transplant patientsChristina Hartmann, Marcus Schuchmann, Tim Zimmermann
Medizinische Klinik (Munich, Germany : 1983)|December 20, 2002
[Apoptosis in disease]Marcus Schuchmann, Peter R Galle, Stephan Kanzler
Liver International : Official Journal of the International Association for the Study of the Liver|September 7, 2006
Apoptosis in liver diseaseJörn M Schattenberg, Peter R Galle, Marcus Schuchmann
Journal of Gastroenterology and Hepatology|January 5, 2011
Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathwaysJorn Markus Schattenberg, Marcus Schuchmann, Peter Robert Galle
Pageof 9